Publications by authors named "Henryka Mazur-Zielinska"

Due to an increasing amount of patients on immunosuppressive treatment, the number of tuberculosis (TB) of atypical course and extrapulmonary tuberculosis cases increase. Locomotor system is a place of every fifth case of extrapulmonary TB. Because of lack of characteristic symptoms, as well as rare co-occurrence of active lung lesions in radiological imaging, proper diagnosis is hard to establish.

View Article and Find Full Text PDF

Pulmonary aspergillosis is a condition caused by the fungi Aspergillus. The form of disease depends on the immunological condition of the host organism and other concomitant illnesses that influence the pulmonary tissue. Asthmatic patients, in particular with the severe form of disease, who require the use of systemic glucocorticoids, are predisposed to develop allergic bronchopulmonary aspergillosis.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the effectiveness of the Birmingham Vasculitis Activity Score (BVAS) v3 and the Disease Extent Index (DEI) in measuring disease activity in four main types of childhood systemic vasculitides.
  • A total of 796 patients with conditions like Henoch-Schönlein purpura and polyarteritis nodosa were analyzed, revealing a strong correlation between BVAS and DEI scores, as well as their ability to reflect disease involvement.
  • The findings confirm that both BVAS and DEI are reliable tools for evaluating disease activity in children with these vasculitides.
View Article and Find Full Text PDF

Objectives: Juvenile idiopathic arthritis (JIA) is a chronic inflammatory joint disease affecting children. Even if remission is successfully induced, about half of the patients experience a relapse after stopping anti-inflammatory therapy. The present study investigated whether patients with JIA at risk of relapse can be identified by biomarkers even if clinical signs of disease activity are absent.

View Article and Find Full Text PDF

Objectives: Juvenile localized scleroderma (JLS) usually has its onset during later childhood. This report describes the clinical and serologic features of six children with congenital localized scleroderma (CLS).

Study Design: A large, multinational study was conducted among pediatric rheumatology and dermatology centers by collecting information on demographics, family history, triggering environmental factors, clinical features, laboratory reports, and treatment of patients with JLS.

View Article and Find Full Text PDF

Objective: Juvenile localized scleroderma is usually considered a disease that is confined to the skin and subcutaneous tissue. We studied the prevalence and clinical features of extracutaneous manifestations in a large cohort of children with juvenile localized scleroderma.

Methods: Data from a multinational study on juvenile scleroderma was used for this in-depth study.

View Article and Find Full Text PDF